The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain

[1]  T. Beccari,et al.  Emerging therapies and therapeutic concepts for lysosomal storage diseases , 2016 .

[2]  C. Auray-Blais,et al.  A metabolomic study to identify new globotriaosylceramide-related biomarkers in the plasma of Fabry disease patients. , 2013, Analytical chemistry.

[3]  T. Kirkegaard.  Emerging therapies and therapeutic concepts for lysosomal storage diseases , 2013 .

[4]  D. Lockhart,et al.  Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb3) in Fabry Transgenic Mice and in the Plasma of Fabry Patients , 2013, PloS one.

[5]  C. Auray-Blais,et al.  A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers. , 2012, Current medicinal chemistry.

[6]  A. Dickenson,et al.  Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons , 2012, Nature Communications.

[7]  William A Catterall,et al.  Voltage-Gated Calcium Channels , 2011 .

[8]  Charles M Perou,et al.  Systems biology and genomics of breast cancer. , 2011, Cold Spring Harbor perspectives in biology.

[9]  R. Brady,et al.  Elevated globotriaosylsphingosine is a hallmark of Fabry disease , 2008, Proceedings of the National Academy of Sciences.

[10]  T. Jensen,et al.  Neurological manifestations in Fabry's disease , 2007, Nature Clinical Practice Neurology.

[11]  R. Schiffmann,et al.  The Relationship of Vascular Glycolipid Storage to Clinical Manifestations of Fabry Disease: A Cross-Sectional Study of a Large Cohort of Clinically Affected Heterozygous Women , 2005, Medicine.

[12]  K. Mills,et al.  Is globotriaosylceramide a useful biomarker in Fabry disease? , 2005, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[13]  K. Mills,et al.  Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease , 2005, Journal of Inherited Metabolic Disease.

[14]  M. Tymianski,et al.  Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. , 2003, Cell calcium.

[15]  C. Stucky,et al.  Differential response properties of IB(4)-positive and -negative unmyelinated sensory neurons to protons and capsaicin. , 2003, Journal of neurophysiology.

[16]  M. Brys,et al.  Small Fiber Dysfunction Predominates in Fabry Neuropathy , 2002, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[17]  H. Fabry.  Angiokeratoma corporis diffusum – Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[18]  P. Kostyuk,et al.  Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons , 1999, Neuroscience.

[19]  C. Stucky,et al.  Isolectin B4-Positive and -Negative Nociceptors Are Functionally Distinct , 1999, The Journal of Neuroscience.

[20]  I. Pastan,et al.  alpha-Galactosidase A deficient mice: a model of Fabry disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[22]  E. Logigian,et al.  Nervous system involvement in Fabry's disease: Clinicopathological and biochemical correlation , 1988, Annals of neurology.